VetMedGuide

Vet Med Guide

Companion animal in a veterinary exam setting with medication reference materials.
Pharmaceuticals2026-06-14 · 10 min read

KBroVet (Potassium Bromide): The First FDA-Approved Drug for Canine Idiopathic Epilepsy

KBroVet (potassium bromide), approved January 2026, is the first FDA-approved drug for canine idiopathic epilepsy. How bromide works, monitoring, diet rules, and the phenobarbital comparison.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

On January 21, 2026, the FDA granted full approval to KBroVet (potassium bromide chewable tablets) for the control of seizures associated with idiopathic epilepsy in dogs. It is the first drug the agency has fully approved for that indication, and the molecule itself — potassium bromide — has been one of the two mainstays of canine seizure control for the better part of a century without ever carrying a formal veterinary approval. That gap is now closed.

The approval matters less because the drug is new than because the label, the formulation, and the manufacturing standards are now fixed. Veterinarians who prescribed compounded potassium bromide for decades now have a consistent, flavored chewable tablet made to approved specifications, with a labeled dose range and a defined safety and monitoring framework. This article explains what KBroVet is, how bromide works, what makes it different from phenobarbital, and the monitoring and diet rules that decide whether it succeeds.

Why an approval for an old drug is still news

Idiopathic epilepsy — recurrent seizures with no identifiable structural or metabolic cause — affects an estimated 5% of dogs, and for most of veterinary history it was treated with whichever human anti-seizure drug a veterinarian reached for. Phenobarbital and potassium bromide were the two anchors, both used off-label. Neither was approved for dogs.

That began to change in January 2021, when the FDA conditionally approved KBroVet-CA1. It was the first conditional approval granted under the agency's expanded conditional-approval authority — a 2018 pathway that allows drugs for serious or life-threatening conditions to reach the market on a demonstration of safety and a reasonable expectation of effectiveness, with full effectiveness data developed during the conditional period. In January 2026, after building that effectiveness evidence, KBroVet became the second animal drug of any kind to graduate from conditional to full FDA approval (after verdinexor, the canine lymphoma drug).

The practical translation: a dog started on KBroVet in 2026 is getting the same molecule veterinarians have trusted for decades, but from an approved, consistently manufactured, palatable, accurately dosed product rather than a compounded preparation of variable concentration.

How bromide stops a seizure

Potassium bromide is a halide salt. After it is absorbed, the bromide ion competes with chloride for entry into the central nervous system. As bromide accumulates in brain tissue and chloride is relatively displaced, neurons become hyperpolarized — their membranes become harder to depolarize — which raises the seizure threshold and stabilizes them against the runaway electrical discharge that produces a seizure.

This chloride-competition mechanism is the reason for the drug's two most important real-world properties. First, it is genuinely long-acting: the elimination half-life of bromide in dogs is roughly 21 days (longer in some individuals), so a single missed dose barely moves blood levels. That is a meaningful advantage for an owner who occasionally forgets, and it is why KBroVet is given just once daily. Second — and this is the catch — bromide levels are sensitive to dietary chloride, because the kidneys handle the two ions together. That sensitivity drives the diet rules below.

How it is dosed and given

KBroVet is a 250 mg chewable tablet, given orally once daily, with or without food. The labeled total daily dose range is 25–68 mg/kg (about 11–31 mg/lb), adjusted to the individual dog's clinical response and serum bromide level. Because steady state takes weeks to reach on that long half-life, veterinarians sometimes use an initial loading regimen to bring therapeutic levels up faster — a decision that weighs the time to seizure control against the sedation that loading can cause.

Two administration points are easy to get wrong and worth stating plainly:

  • Do not change the dog's diet abruptly. This is the single most important handling rule for any bromide product, and it is baked into KBroVet's labeling. Increased dietary salt (chloride) speeds bromide elimination and can drop levels enough to trigger seizures; a switch to a low-salt diet can push levels into toxicity. Even switching between two commercial dry foods can matter, because chloride content varies widely between brands. If a diet change is needed, it should happen gradually and with a recheck of the bromide level.
  • Expect drowsiness during loading. Profound sedation is common when therapy starts, particularly with a loading dose. If a dog is groggy, the answer is to call the veterinarian and adjust — not to give the next scheduled dose, which can compound the sedation.

How it compares to phenobarbital

Most owners weighing KBroVet are comparing it to phenobarbital, the other long-standing anchor of canine epilepsy management. The two are similarly effective as first-choice monotherapy, but they differ in ways that matter to individual dogs:

Potassium bromide (KBroVet) Phenobarbital
Route of elimination Kidneys Liver
Typical side-effect burden Generally fewer; sedation, PU/PD Sedation, ataxia, polyphagia
Lab monitoring Serum bromide level Phenobarbital level, liver enzymes (ALT, ALP), CBC
Notable risks Bromide intoxication; pancreatitis (esp. with phenobarbital) Hepatotoxicity with chronic use
Best-fit patient Hepatic disease; intolerant of phenobarbital Renal disease; need for faster onset

The single biggest decision driver is the liver. Bromide is cleared by the kidneys, not metabolized by the liver, so it has long been the preferred option for dogs with compromised liver function who cannot tolerate a drug the liver must process. Phenobarbital, by contrast, requires periodic liver-enzyme monitoring because chronic use can cause hepatic injury. The two drugs are also used together — combination therapy lets a veterinarian lower the phenobarbital dose and with it the liver burden — but that combination raises the pancreatitis risk, so it is not a casual add-on.

Worth noting: the off-label era is closing for both anchors. Phenobarbital itself now carries a conditional canine epilepsy label (Fidoquel-CA1, Genus Lifesciences, conditionally approved in 2023), so KBroVet and Fidoquel-CA1 are the two products the FDA has recognized for this indication — a meaningful shift for a field that relied on borrowed human drugs for a century.

For a broader picture of how seizure disorders are worked up before any drug is chosen — differentiating idiopathic epilepsy from structural brain disease, toxins, and metabolic causes — see the Seizures in Dogs workup guide.

Who is not a candidate, and what to watch

KBroVet's label states plainly that it is not for use in cats. In cats, bromide carries a risk of serious lung disease — coughing and breathing difficulty that can become life-threatening — in addition to the side effects seen in dogs. Cats with seizures are managed with other drugs.

In dogs, the central safety concern is bromide intoxication (bromism). A systematic review of potassium bromide safety in dogs, published in JAVMA and hosted by the FDA, found neurologic signs to be the most common adverse drug events: sedation, irritability, restlessness, depression, behavioral changes, ataxia, hind-limb paresis, stupor, and — at the extreme — coma. These signs are reversible. They typically ease within several days of reducing the dose, and they can be reversed within hours by intravenous 0.9% saline, because the chloride load drives bromide back out. The same mechanism is why furosemide and other chloride-affecting treatments also lower bromide levels, and why chloride-containing IV fluids during a hospital stay or anesthetic event can drop bromide below the therapeutic range — worth flagging to any veterinarian handling a sedation on a treated dog.

Separate from intoxication, bromide has a set of routine, expected effects the FDA-cleared label lists directly: increased appetite and weight gain, vomiting or regurgitation, sedation, ataxia or weakness, and the increased thirst and urination that come from giving a salt every day. These are the everyday side effects owners recognize and manage; the intoxication signs above are what happens when levels climb too high.

Four other points a reasonable owner should know:

  • Pancreatitis. Dogs with a history of pancreatitis can flare on bromide, and the risk is higher when bromide is combined with phenobarbital. A dog with vomiting and abdominal pain on bromide should be evaluated, not assumed to have simple GI upset.
  • Kidney disease. Because bromide leaves the body through the kidneys, dogs with poor renal function may not clear it normally and can accumulate toxic levels on a standard dose.
  • Breeding, pregnancy, and young puppies. The label states that the safe use of KBroVet has not been established in dogs intended for breeding, pregnant or lactating bitches, or puppies under six months of age — so those are situations that call for explicit veterinary judgment rather than a routine refill.
  • It is a lifelong commitment. Epilepsy medication is not a course of treatment that ends. Stopping suddenly can precipitate more severe seizures. If bromide ever needs to be discontinued, it is tapered under veterinary guidance.

What to ask your veterinarian

KBroVet does not change whether your dog needs anti-seizure medication — that decision comes from the workup, the seizure frequency, and the risk of cluster or status epilepticus. It changes the quality and consistency of the bromide option. If your dog has idiopathic epilepsy, the conversation to have is about fit and monitoring:

  • Is bromide or phenobarbital the better first choice for this dog, given liver and kidney health?
  • Should we use a loading dose, and what sedation should I expect in the first weeks?
  • When do we check a serum bromide level, and what target are we aiming for?
  • What diet is this dog on, and what do I do if that diet needs to change?
  • What counts as bromide toxicity at home — what signs send us back to the clinic?

For the great majority of dogs with idiopathic epilepsy, medication is about reducing seizure frequency and severity to a level that lets the dog live a normal life, not about eliminating seizures entirely. KBroVet brings the bromide half of that effort under a labeled, approved, reliably made roof — and for the dogs whose livers argue against phenobarbital, it has long been, and now formally is, a first option rather than a fallback.

Sources

Topics
Drug Safety & Toxicology
Related Articles